It is one of the common bone health disorders which is known to cause significant disease burden both in developed and developing countries. Due to its major interference in the routine activities of daily living, it significantly affects the quality of life of the patients.
Ongoing research in osteoporosis is focused on better understanding the mechanisms of bone loss, the development of more effective treatments, and improving early detection. Current studies are investigating the role of genetics and epigenetics in bone health, with researchers exploring how genetic variations contribute to osteoporosis risk. There's also significant focus on bone turnover markers and novel biomarkers like sclerostin and periostin that can provide insights into bone formation and resorption processes. Additionally, advances in imaging technologies like high-resolution peripheral quantitative computed tomography (HR-pQCT) are helping researchers visualize bone microarchitecture in detail, aiding in early diagnosis and monitoring of disease progression. Furthermore, clinical trials are examining new therapies, including monoclonal antibodies targeting proteins involved in bone resorption, such as RANKL inhibitors and sclerostin inhibitors, to enhance bone density and prevent fractures. This research is crucial in addressing the increasing global burden of osteoporosis, particularly in aging populations, and improving the quality of life for patients.
Insight to Osteoporosis Biospecimens We Offer:
Since 2017, Central BioHub is in the frontline of global biospecimen providers offering top quality clinical research samples. Our service is much appreciated by international researchers, making us one of the most trusted partners for biospecimen procurement. Say goodbye to the old tedious biosample acquisition process. Our online human biospecimen marketplace can fulfill your research needs without any waiting time.
Promotion of research at all levels is inevitable to deal with growing disease incidence and bone loss. Therefore, Central BioHub offers a curated collection of osteoporosis samples such as human serum and plasma samples obtained from consented patients diagnosed with osteoporosis or patients exhibiting osteoporosis symptoms. We offer bone disease specimens (osteoporosis biomarker) that are screened for routine disease parameters like Rheumatoid factor antibody (RF), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP samples), and anti-citrullinated protein/peptide antibodies (ACPA/anti-CCP), calcium levels, uric acid levels, and bone alkaline phosphatase levels. The research samples are well preserved in perfect condition at our supplier’s biobank. Moreover, we offer well-annotated samples with patients’ medical conditions, medication details, and demographic details such as age, sex, ethnicity and country of sample origin. Being a customer-centric company, we value the time and patience of our clients. Therefore, we process every sample request with no waiting time and dispatches to your facility at the earliest. Check out our inventory to purchase safe, reliable, high-quality, and cost-effective osteoporosis samples for research. Reach out to our customer management experts for more details on musculoskeletal disorder samples. We are happy to help you!
Also, explore advanced search options by clicking Clinical Diagnosis, ICD-10-CM codes, Matrix, and Laboratory Parameters.